Left main disease management strategy: indications and revascularization methods in particular groups of subjects

Cardiol J. 2012;19(4):347-54. doi: 10.5603/cj.2012.0064.

Abstract

Surgical revascularization with coronary artery by-pass grafting is still recommended in vast majority of patients with unprotected left main disease. The aim of the paper was to analyze optimal treatment of left main disease in selected groups of patients, on the basis of current guidelines and information gained from literature data. We focused on data in relation to treatment of elderly patients, diabetics and those hemodynamically unstable. Additionally we discussed the issue of anti-platelet therapy and informed consent. As far as efficacy of treatment is concerned, not only method of revascularization but also general condition of the patient, the factors influencing peri-operative risk and optimal pharmacotherapy should be taken into account. Therefore establishment of the heart team is crucial when choosing the most suitable method of invasive treatment of left main disease.

Publication types

  • Review

MeSH terms

  • Cardiovascular Agents / therapeutic use
  • Coronary Artery Bypass* / adverse effects
  • Coronary Artery Bypass* / standards
  • Coronary Stenosis / diagnostic imaging
  • Coronary Stenosis / surgery
  • Coronary Stenosis / therapy*
  • Humans
  • Informed Consent
  • Patient Selection
  • Percutaneous Coronary Intervention* / adverse effects
  • Percutaneous Coronary Intervention* / standards
  • Practice Guidelines as Topic
  • Radiography
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents